-
-
-
-
-
-
-
U.S. Biotech stocks: Q1 earnings previews
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
-
-
-
-
-
-
-
Alnylam Pharmaceuticals (ALNY) PT Raised to $450 at Scotiabank
-
-
-
-
-
-
-
Alnylam Pharma (ALNY) Tops Q1 EPS by 92c
-
-
-
-
-
-
-
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Period Progress
-
-
-
-
-
-
-
Alnylam Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Period Activity
-
-
-
-
-
-
-
Alnylam Pharma (ALNY) Tops Q1 EPS by 98c; reiterates guidance
-
1,215,815 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

